Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma
Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma have?
Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma has 7 citations in the OpenAlex counts ScholarIQ stores.
When was Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma published?
Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma has 2024 year in the ScholarIQ index.
What is the open-access status of Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma?
Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma has gold oa status in the ScholarIQ index.
What is the DOI of Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma?
The DOI for Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma is on the source record.
What is the PMID of Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma?
The PMID for Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma is on the source record.
What is the OpenAlex record for Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma?
The OpenAlex for Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma is on the source record.